Polyglutamine repeat length-dependent proteolysis of huntingtin

Neurobiology of Disease

Volumn 11, Issue 1, 2002, Pages 111-122

  Sun, Banghua ^a   Fan, Wei ^a   Balciunas, Aldona ^a   Cooper, Jillian K ^b   Bitan, Gal ^c   Steavenson, Shirley ^a   Denis, Paul E ^a   Young, Yunjen ^a   Adler, Beverly ^a   Daugherty, Larry ^a   Manoukian, Raffi ^a   Elliott, Gary ^a   Shen, Wenyan ^a   Talvenheimo, Jane ^a   Teplow, David B ^c   Haniu, Mitsuru ^a   Haldankar, Raj ^a   Wypych, Jette ^a   Ross, Christopher A ^b   Citron, Martin ^a   Richards, William G ^a   more..

^a AMGEN INC   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; HUNTINGTIN; POLYGLUTAMINE;

AGED; AMINO ACID ANALYSIS; ANIMAL CELL; ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; HUNTINGTON CHOREA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION;

EID: 0036451321     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1006/nbdi.2002.0539     Document Type: Article

References (42)

1. Allen, T. D., Cronshaw, J. M., Bagley, S., Kiseleva, E., & Goldberg, M. W. (2000) The nuclear pore complex: Mediator of translocation between nucleus and cytoplasm. J. Cell. Sci. 113, 1651-1659.
2. Brinkman, R. R., Mezei, M. M., Theilmann, J., Almqvist, E., & Hayden, M. R. (1997) The likelihood of being affected with Huntington disease by a particular age, for a specific CAG size. Am. J. Hum. Genet. 60, 1202-1210.
3. Cha, J. H. J. (2000) Transcriptional dysregulation in Huntington's disease. Trends Neurosci. 23, 387-392.
4. Cooper, J. K., Schilling, G., Peters, M. F., Herring, W. J., Sharp, A. H., Kaminsky, Z., Masone, J., Khan, F. A., Delanoy, M., Borchelt, D. R., Dawson, V. L., Dawson, T. M., & Ross, C. A. (1998) Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. Hum. Mol. Genet. 7, 783-790.
5. Cummings, C. J., Mancini, M. A., Antalffy, B., DeFranco, D. B., Orr, H. T., & Zoghbi, H. Y. (1998) Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1. Nature Genet. 19, 148-154.
6. Cummings, C. J., & Zoghbi, H. Y. (2000) Trinucleotide repeats: Mechanisms and pathophysiology. Annu. Rev. Genomics Hum. Genet. 1, 281-328.
7. DiFiglia, M., Sapp, E., Chase, K. O., Davies, S. W., Bates, G. P., Vonsattel, J. P., & Aronin, N. (1997) Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science 277, 1990-1993.
8. Furtado, S., Suchowersky, O., Rewcastle, B., Graham, L., Klimek, M. L., & Garber, A. (1996) Relationship between trinucleotide repeats and neuropathological changes in Huntington's disease. Ann. Neurol. 39, 132-136.
9. Goerlich, D., & Mattaj, L. W. (1996) Nucleocytoplasmic transport. Science 271, 1513-1518.
10. Goldberg, Y. P., Nicholson, D. W., Rasper, D. M., Kalchman, M. A., Koide, H. B., Graham, R. K., Bromm, M., KazemiEsfarjani, P., Thornberry, N. A., Vaillancourt, J. P., & Hayden, M. R. (1996) Cleavage of huntingtin by apopain, a proapoptotic cysteine protease, is modulated by the polyglutamine tract. Nature Genet. 13, 442-449.
11. Gusella, J. F., & MacDonald, M. E. (1998) Huntingtin: A single bait hooks many species. Curr. Opin. Neurobiol. 8, 425-430.
12. Gusella, J. F., McNeil, S., Persichetti, F., Srinidhi, J., Novelletto, A., Bird, E., Faber, P., Vonsattel, J. P., Myers, R. H., & MacDonald, M. E. (1996) Huntington's disease. Cold Spring Harbor Symp. Quant. Biol. 61, 615-626.
13. Hackam, A. S., Singaraja, R., Zhang, T. Q., Gan, L., & Hayden, M. R. (1999) In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease. Hum. Mol. Genet. 8, 25-33.
14. Hackam, A. S., Yassa, A. S., Singaraja, R., Metzler, M., Gutekunst, C. A., Gan, L., Warby, S., Wellington, C. L., Vaillancourt, J., Chen, N. S., Gervais, F. G., Raymond, L., Nicholson, D. W., & Hayden, M. R. (2000) Huntingtin interacting protein 1 induces apoptosis via a novel caspase-dependent death effector domain. J. Biol. Chem. 275, 41299-41308.
15. Kalchman, M. A., Koide, H. B., McCutcheon, K., Graham, R. K., Nichol, K., Nishiyama, K., KazemiEsfarjani, P., Lynn, F. C., Wellington, C., Metzler, M., Goldberg, Y. P., Kanazawa, I., Gietz, R. D., & Hayden, M. R. (1997) HIP1, a human homologue of S-cerevisiae Sla2p, interacts with membrane-associated huntingtin in the brain. Nature Genet. 16, 44-53.
16. Kim, M., Lee, H. S., LaForet, G., McIntyre, C., Martin, E. J., Chang, P., Kim, T. W., Williams, M., Reddy, P. H., Tagle, D., Boyce, F. M., Won, L., Heller, A., Aronin, N., & DiFiglia, M. (1999) Mutant huntingtin expression in clonal striatal cells: Dissociation of inclusion formation and neuronal survival by caspase inhibition. J. Neurosci. 19, 964-973.
17. Kim, Y., Yi, Y., Sapp, E., Wang, Y., Cuiffo, B., Kegel, K., Qin, Z., Aronin, N., & DiFiglia, M. (2001) Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc. Natl. Acad. Sci. USA 98, 12784-12789.
18. Kuemmerle, S., Gutekunst, C. A., Klein, A. M., Li, X. J., Li, S. H., Beal, M. F., Hersch, S. M., & Ferrante, R. J. (1999) Huntingtin aggregates may not predict neuronal death in Huntington's disease. Ann. Neurol. 46, 842-849.
19. Leavitt, B. R., Wellington, C. L., & Hayden, M. R. (1999) Recent insights into the molecular pathogenesis of Huntington disease. Semin. Neurol. 19, 385-395.
20. Li, H., Li, S. H., Johnston, H., Shelbourne, P. F., & Li, X. J. (2000) Amino-terminal fragments of mutant huntingtin show selective accumulation in striatal neurons and synaptic toxicity. Nature Genet. 25, 385-389.
21. Lunkes, A., & Mandel, J. L. (1998) A cellular model that recapitulates major pathogenic steps of Huntington's disease. Hum. Mol. Genet. 7, 1355-1361.
22. MacDonald, M. E. (1998) Molecular genetics of Huntington's disease. Results Probl. Cell. Differ. 21, 47-75.
23. MacDonald, M. E., & Gusella, J. F. (1996) Huntington's disease: Translating a CAG repeat into a pathogenic mechanism. Curr. Opin. Neurobiol. 6, 638-643.
24. McCampbell, A., Taylor, J. P., Taye, A. A., Robitschek, J., Li, M., Walcott, J., Merry, D., Chai, Y. H., Paulson, H., Sobue, G., & Fischbeck, K. H. (2000) CREB-binding protein sequestration by expanded polyglutamine. Hum. Mol. Genet. 9, 2197-2202.
25. Mende-Mueller, L. M., Toneff, T., Hwang, S. R., Chesselet, M. F., & Hook, V. Y. H. (2001) Tissue-specific proteolysis of huntingtin (htt) in human brain: Evidence of enhanced levels of N- and C-terminal htt fragments in Huntington's disease striatum. J. Neurosci. 21, 1830-1837.
26. Nucifora, F. C., Sasaki, M., Peters, M. F., Huang, H., Cooper, J. K., Yamada, M., Takahashi, H., Tsuji, S., Troncoso, J., Dawson, V. L., Dawson, T. M., & Ross, C. A. (2001) Interference by Huntingtin and atrophin-1 with CBP-mediated transcription leading to cellular toxicity. Science 291, 2423-2428.
27. Peters, M. F., Nucifora, F. C., Kushi, J., Seaman, H. C., Cooper, J. K., Herring, W. J., Dawson, V. L., Dawson, T. M., & Ross, C. A. (1999) Nuclear targeting of mutant huntingtin increases toxicity. Mol. Cell. Neurosci. 14, 121-128.
28. Preisinger, E., Jordan, B. M., Kazantsev, A., & Housman, D. (1999) Evidence for a recruitment and sequestration mechanism in Huntington's disease. Philos. Trans. R. Soc. Lond. Ser. B Biol. Sci. 354, 1029-1034.
29. Rosenblatt, A., Brinkman, R. R., Liang, K. Y., Almqvist, E. W., Margolis, R. L., Huang, C. Y., Sherr, M., Franz, M. L., Abbott, M. H., Hayden, M. R., & Ross, C. A. (2001) Familial influence on age of onset among siblings with Huntington disease. Am. J. Med. Genet. 105, 399-403.
30. Ross, C. A., Margolis, R. L., Becher, M. W., Wood, J. D., Engelender, S., Sharp, A. H., Wells, R. D., Warren, S. T., & Sarmiento, M. (1998). Genetic Instabilities and Hereditary Neurological Diseases, pp. 761-776.
31. Saudou, F., Finkbeiner, S., Devys, D., & Greenberg, M. E. (1998) Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions. Cell 95, 55-66.
32. Shimohata, T., Nakajima, T., Yamada, M., Uchida, C., Onodera, O., Naruse, S., Kimura, T., Koide, R., Nozaki, K., Sano, Y., Ishiguro, H., Sakoe, K., Ooshima, T., Sato, A., Ikeuchi, T., Oyake, M., Sato, T., Aoyagi, Y., Hozumi, I., Nagatsu, T., Takiyama, Y., Nishizawa, M., Goto, J., Kanazawa, I., Davidson, I., Tanese, N., Takahashi, H., & Tsuji, S. (2000) Expanded polyglutamine stretches interact with TAF(II)130, interfering with CREB-dependent transcription. Nature Genet. 26, 29-36.
33. Sisodia, S. S. (1998) Nuclear inclusions in glutamine repeat disorders: Are they pernicious, coincidental, or beneficial? Cell 95, 1-4.
34. Sorimachi, H., & Suzuki, K. (1998) In: Handbook of Proteolytic Enzymes (A. J. Barrett, N. D. Rawlings, & J. F. Woessner, Eds.), pp 649-654. Academic Press, San Diego.
35. Steffan, J. S., Kazantsev, A., Spasic, B. O., Greenwald, M., Zhu, Y. Z., Gohler, H., Wanker, E. E., Bates, G. P., Housman, D. E., & Thompson, L. M. (2000) The Huntington's disease protein interacts with p53 and CREB-binding protein and represses transcription. Proc. Natl. Acad. Sci. USA 97, 6763-6768.
36. Trottier, Y., Lutz, Y., Stevanin, G., Imbert, G., Devys, D., Cancel, G., Saudou, F., Weber, C., David, G., Tora, L., Agid, Y., Brice, A., & Mandel, J. L. (1995) Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 378, 403-406.
37. Vonsattel, J. P. G., & DiFiglia, M. (1998) Huntington disease. J. Neuropathol. Exp. Neurol. 57, 369-384.
38. Wainwright, M. S., Perry, B. D., Won, L. A., Omalley, K. L., Wang, W. Y., Ehrlich, M. E., & Heller, A. (1995) Immortalized murine striatal neuronal cell lines expressing dopamine receptors and cholinergic properties. J. Neurosci. 15, 676-688.
39. Wanker, E. E., Rovira, C., Scherzinger, E., Hasenbank, R., Walter, S., Tait, D., Colicelli, J., & Lehrach, H. (1997) HIP-I: A huntingtin interacting protein isolated by the yeast two-hybrid system. Hum. Mol. Genet. 6, 487-495.
40. Wellington, C. L., Ellerby, L. M., Hackam, A. S., Margolis, R. L., Trifiro, M. A., Singaraja, R., McCutcheon, K., Salvesen, G. S., Propp, S. S., Bromm, M., Rowland, K. J., Zhang, T. Q., Rasper, D., Roy, S., Thornberry, N., Pinsky, L., Kakizuka, A., Ross, C. A., Nicholson, D. W., Bredesen, D. E., & Hayden, M. R. (1998) Caspase cleavage of gene products associated with triplet expansion disorders generates truncated fragments containing the poly-glutamine tract. J. Biol. Chem. 273, 9158-9167.
41. Wellington, C. L., Leavitt, B. R., & Hayden, M. R. (2000a) Huntington disease: New insights on the role of huntingtin cleavage. J. Neural Transm. Suppl. 58, 1-17.
42. Wellington, C. L., Singaraja, R., Ellerby, L., Savill, J., Roy, S., Leavitt, B., Cattaneo, E., Hackam, A., Sharp, A., Thornberry, N., Nicholson, D. W., Bredesen, D. E., & Hayden, M. R. (2000b) Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and nonneuronal cells. J. Biol. Chem. 275, 19831-19838.